Group items tagged

Cardiac markers are special antibodies measured in the blood to measure heart function. They can also be used in the detection or early diagnosis of certain diseases. Although they're usually associated with myocardial infarction, they can also be indicative of many other conditions. For instance, hyperthyroidism and thyroid prophylaxis can result in an elevated elevation in plasma marker levels. As per the American Heart Association (AMA), in 2016, cardiovascular disease accounted for 17.6 million deaths across the globe. The ECG is one of the most useful cardiac marker testing device. It measures the cardiac output and provides detailed information about heart conditions. This test is used to diagnose heart diseases and the complications that can arise from the disease. ECG is one of the most widely used tests. ECG is conducted while the patient is lying down on the table. A technician places electrodes either in or on the skin surface. The test is normally performed for different purposes. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2021/03/cardiac-marker-testing-devices-have.html

An experimental device made from layered filter paper is helping Rice University bioengineers study calcifying heart diseases. The filter paper is structured in a way that mimics the layering of aortic heart valves, recreating the means by which cells spread through cardiac tissue in a laboratory setting. It may not look much like a heart valve, but in practice it simulates the proliferation process in the same way.

Pulmonary Arterial Hypertension (PAH) is a disease that affects the vasculature of the heart, specifically the arteries that transport blood from the heart to the lungs. Common symptoms include heart palpitations or an irregular rhythm, chest pain, coughing, wheezing, shortness of breath, chest discomfort when breathing, and sometimes even heart failure. The cause of pulmonary hypertension is not known, but research has indicated that genetic and hormonal factors may play a role in its development. The growing prevalence of Pulmonary Arterial Hypertension (PAH) is driving the growth of the Pulmonary Arterial Hypertension (PAH) Market. According to the European Respiratory Society, PAH is a rare disease, with an estimated prevalence ranging from 10 to 52 cases per million. The growing geriatric population is again increasing the prevalence of such disease which is also projected to foster the growth of the Pulmonary Arterial Hypertension (PAH) market. According to the United nation, by 2050, one in six people in the world will be over age 65 (16%), up from one in 11 in 2019 (9%). By 2050, one in four persons living in Europe and Northern America could be aged 65 or over. North America is projected to gain significant growth over the forecast period and this is attributed to the growing adoption of advanced treatment for treating pulmonary arterial hypertension. Moreover, increasing spending by the government on the healthcare sector is again augmenting the regional market growth. According to the U.S. Centers for Medicare & Medicaid Services, National health spending is projected to grow at an average annual rate of 5.4 percent for 2019-28 and to reach $6.2 trillion by 2028. Reads more @ https://coherentmarketinsights-blog.blogspot.com/2021/02/increasing-global-healthcare-spending.html

The tool uses information such as blood pressure, cholesterol levels, and blood sugar levels to help determine a level of risk for heart problems. Upon completing the questionnaire, users can print various reports to help them make a plan with their doctor to reduce their risk.

Mitral clip is a niche device to treat patients with severe mitral valve leak without open heart surgery in Apollo Hospitals Mumbai. MitraClip allows the mitral valve to close more completely, helping to restore normal blood flow through the heart. It's a minimally invasive treatment option for patients with mitral regurgitation.

Clinical Risk Management Lies at the Heart of Patient Safety : Clinical Risk Management is the process of identifying and mitigating risks in a healthcare setting. Risks are inherent in a clinical or healthcare practice, as they are in any other activity. But the field of healthcare has to be doubly wary of risk management because an adverse risk can cause irreparable loss if it leads to an event such as death. To a healthcare organization or practice, a bad event can harm the name beyond repair. How is risk identified? The first step to implementing a Clinical Risk Management is identifying the risks in the practice. This can be done in a number of ways: Why do healthcare providers need to implement a Clinical Risk Management strategy? Healthcare providers need to put in place a very sound Clinical Risk Management strategy for a number of reasons: Steps to putting a good Clinical Risk Management program in place A healthcare organization can put an effective Clinical Risk Management in place through a four-step process: Click Here for More Information: http://bit.ly/1OcHFXm

The broad influence of the COVID-19 pandemic is likely to help heart disease remain the prime cause of death for the years to come.

Hyperphosphatemia is a condition caused by high levels of phosphorous or phosphate in the blood. This condition may be due to decreased emission of phosphate, excessive intake of phosphate, and the shift of phosphate from intracellular to extracellular. High phosphate levels in the blood can be avoided with the use of phosphate binders or by dietary restrictions. Phosphate is a chemical found in the human body and contains a mineral called phosphorous. It is important for the development of bones and teeth and also converts food into energy for the body. Some other possible causes of hyperphosphatemia include low levels of parathyroid hormone, high levels of vitamin D, uncontrolled diabetes, and diabetic ketoacidosis. The factors such as the growing geriatric population and increasing prevalence of chronic diseases worldwide are expected to drive the hyperphosphatemia drugs market in the coming future. Hyperphosphatemia is a primary cause of mortality and morbidity in people with chronic kidney disease. According to the Centers for Disease Control and Prevention (CDC), around 37 million adults in the United States are likely to have chronic kidney disease and most are undiagnosed. It is rare in the general population, but in people with chronic kidney disease, the rate of hyperphosphatemia is at least 70%. Since the increased risk of death from heart disease and hyperphosphatemia are associated with each other. This, in turn, increases the risk of heart disease in people suffering from hyperphosphatemia. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/increasing-prevalence-of-chronic-kidney.html

Avocado oil is an edible oil extracted from the pulp of avocados, the fruit of Persea Americana. It is a heart-healthy oil, high in oleic acid, which is an unsaturated fat. It is a good source of monounsaturated fat that has been linked to increasing HDL cholesterol and reducing LDL cholesterol. Moreover, avocado oil help control of psoriasis and osteoarthritis, and some of the benefits associated with avocado oil make it useful for the treatment of carotid artery disease, peripheral artery disease, and coronary heart disease, among others. Furthermore, due to its moisturizing and regenerative properties, avocado oil is widely used in the cosmetic industry. The beta carotene, fatty acids, lecithin, protein, and vitamins E, D, and A found in avocado oil help protect and moisturize the skin from damaging UV rays and also increase collagen metabolism. Read more @ https://sachinbhombe.blogspot.com/2021/08/avocado-oil-better-suited-for-high-heat.html

Are you worried you are getting heavier day by day? Well, it might be because of those fries you are addicted to. Deep fried foods are rich in trans fats which are directly related to obesity and heart failure. Trans fats build up the blood vessels, hindering the smooth flow of blood through them.

Apollo Hospitals Mumbai offers Interventional Cardiology that specifically deals with the catheter based treatment of structural heart diseases.

Apollo Hospitals Mumbai offers electrophysiology with the treatment of arrhythmia for heart patients in Mumbai.

Corona indeed has been the highest scorer for the number of lives claimed in the year 2020. Wherein coronavirus has grabbed all the attention in the medical fraternity across the world, Have you ever imagined, what are the other life-threatening diseases in the country, that has outperformed any other country(measured by population) in controlling the spread of coronavirus? When Covid-19 has caused an alarming situation in the world, and now that all of us are even more aware of our health, fitness, and lifestyles, Let's look at the other big killers in our country like Heart Diseases, Diabetes Mellitus, Road Injury/Accidents, etc.

How to prevent and get rid of blood clots * Grapes: Grapes contain resveratrol, which reduces heart attacks, and the first to discover it were the Japanese. It is preferable to eat fresh grapes or its juice, but taking care to stay away from grapes sprinkled with chemical pesticides, and it can be eaten after the three main meals.....

Rationale for Clinical Trial Regulations Clinical trials, as we all know, are carried out to test the efficacy of a new drug or device being developed for a specific condition or disease. Clinical trials are experiments that have a high degree of risk if they are not properly implemented. For this reason, it is necessary for regulatory bodies to regulate clinical trials. The core rationale for regulating the various stages of clinical trials is that human subjects, who are part of the research, have to be protected. These clinical trial regulations are legislated at all stages: local, State, national and international. Clinical trial regulations are in force in different countries of the world. Common clinical trial regulations are also made globally by the International Conference on Harmonization (ICH), which has the mandate of setting out good practices for clinical trial regulations for trials done in global cooperation. These regulations cover the administrative, procedural and ethical aspects of clinical trials. Briefly, these are the areas in which there are clinical trial regulations for each of these aspects of clinical trials: Administrative: The administrative aspects of clinical trial regulations pertain to the way the clinical trials are run, and the way they are tracked and monitored throughout their lifecycle. A clinical trial is usually monitored by a sponsoring company or a Contract Research Organization (CRO), which the former hires at times for reasons of convenience and cost cutting. Clinical trial regulations in this area is obviously of importance because if something goes wrong at any administrative stage; these can be rectified. Procedural: Procedural aspects of clinical trial regulations relate to ways by which subjects are chosen for a clinical trial. Proper care has to be taken to ensure that the subjects are appropriate for the clinical study, are from the prescribed age, geographical, demographic, racial and gender-related cl